RecruitingNot ApplicableNCT07352215

PRP Plus Fractional CO₂ Laser for Acne Scars

Evaluating the Effectiveness of Platelet-Rich Plasma as an Adjunct to Fractional Carbon Dioxide Laser Therapy in Improving Facial Acne Scar Appearance: A Randomized Controlled Trial


Sponsor

Gujranwala medical college District Headquarters Hospital, Gujranwala

Enrollment

70 participants

Start Date

Oct 31, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

This randomized controlled trial aims to evaluate whether adding platelet-rich plasma (PRP) to fractional CO₂ laser resurfacing improves the treatment of moderate-to-severe acne scars compared with laser alone. Seventy adults aged 18-40 years will be recruited from the Dermatology Department of Gujranwala Medical College Teaching Hospital. Participants will be randomly assigned to receive either fractional CO₂ laser combined with topical PRP or fractional CO₂ laser alone, with three treatment sessions delivered four weeks apart. The primary outcome is the change in acne scar severity measured using the Goodman and Baron Quantitative Acne Scar Scale. Secondary outcomes include redness, edema, pain scores, and patient satisfaction assessed using Likert and numeric rating scales. The study is single-blinded, with patients unaware of treatment allocation. PRP will be prepared using a standardized double-spin centrifugation process. Data will be analyzed using appropriate statistical tests with a significance level of p \< 0.05. The study aims to determine whether PRP enhances laser efficacy, reduces side effects, and improves patient-reported outcomes.


Eligibility

Min Age: 18 YearsMax Age: 40 Years

Inclusion Criteria5

  • Male and female participants
  • Fitzpatrick skin types I to V
  • Presence of moderate-to-severe acne scars
  • Willing to undergo 3 treatment sessions and follow-up visits
  • Able to provide informed consent -

Exclusion Criteria13

  • History of keloid formation or hypertrophic scarring
  • Active acne or active skin inflammation at treatment area
  • Diabetes mellitus
  • Photosensitive disorders (e.g., lupus, dermatomyositis)
  • Melasma
  • Active infections (e.g., Herpes simplex)
  • Recent laser resurfacing or similar procedures
  • Outdoor workers with high sun exposure
  • Vitiligo
  • Pregnancy or breastfeeding
  • Bleeding disorders or anticoagulant therapy
  • Unrealistic expectations or inability to comply with follow-up
  • \-

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREFractional CO₂ Laser + Platelet-Rich Plasma (PRP)

Fractional CO₂ Laser + Platelet-Rich Plasma (PRP) Participants receive fractional CO₂ laser treatment followed by topical application of autologous platelet-rich plasma. Three treatment sessions are performed at four-week intervals. PRP is prepared using a standardized double-spin centrifugation method from 10 mL of the participant's blood. After laser resurfacing, the PRP is applied immediately to the treated area to enhance healing and collagen remodeling.

PROCEDUREFractional CO₂ Laser Only

Fractional CO₂ Laser Only Participants receive fractional CO₂ laser treatment alone, with the same laser settings and treatment schedule as the intervention group. Three sessions are performed at four-week intervals. To maintain participant blinding, a placebo-filled syringe covered with opaque tape is applied to the skin without delivering PRP.


Locations(1)

Destrict Head Quarter Hospital, Gujranwala

Gujranwala, Punjab Province, Pakistan

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07352215


Related Trials